US Pharma MarketingThe post Distalmotion secures second FDA gynaecology clearance for DEXTER system appeared first on Medical Device Network.
Distalmotion secures second FDA gynaecology clearance for DEXTER system
Swiss medical device company Distalmotion has secured the FDA 510(k) clearance for its DEXTER robotic surgery system. The authorisation represents the DEXTER system’s second FDA clearance relating to gynaecology. The system allows surgeons to perform procedures robotically for different gynaecological conditions in outpatient settings. Credit: Distalmotion. Swiss medical device company Distalmotion has secured the US Food and Drug Administration (FDA) 510(k) clearance for its DEXTER robotic surgery system, covering sacrocolpopexy, sacrocervicopexy, sacrohysteropexy, and endometriosis resection. These new indications build on previous US authorisations that included hysterectomy and salpingo-oophorectomy for gynaecological use. Combine business intelligence and editorial excellence to reach engaged…
Swiss medical device company Distalmotion has secured the FDA 510(k) clearance for its DEXTER robotic surgery system.
Source: Medical Device Network